Skip to Content

Roche Holding AG RHHVF

Morningstar Rating
$262.50 +2.00 (0.77%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RHHVF is trading at a 20% discount.
Price
$263.47
Fair Value
$366.94
Uncertainty
Very High
1-Star Price
$529.64
5-Star Price
$975.86
Economic Moat
Wbrs
Capital Allocation
Kvycktngh
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RHHVF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$260.50
Day Range
$262.50265.10
52-Week Range
$252.87323.78
Bid/Ask
$260.00 / $269.00
Market Cap
$209.28 Bil
Volume/Avg
1,022 / 4,422

Key Statistics

Price/Earnings (Normalized)
12.05
Price/Sales
3.14
Dividend Yield (Trailing)
3.90%
Dividend Yield (Forward)
4.79%
Total Yield
3.90%

Company Profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Core
Total Number of Employees
103,605

Competitors

Valuation

Metric
RHHVF
ABBV
MRK
Price/Earnings (Normalized)
12.0516.1084.63
Price/Book Value
6.0030.508.55
Price/Sales
3.145.845.38
Price/Cash Flow
11.5515.8421.26
Price/Earnings
RHHVF
ABBV
MRK

Financial Strength

Metric
RHHVF
ABBV
MRK
Quick Ratio
0.990.630.68
Current Ratio
1.350.871.25
Interest Coverage
14.933.572.33
Quick Ratio
RHHVF
ABBV
MRK

Profitability

Metric
RHHVF
ABBV
MRK
Return on Assets (Normalized)
17.03%14.54%3.59%
Return on Equity (Normalized)
53.42%150.11%9.12%
Return on Invested Capital (Normalized)
26.30%28.30%5.88%
Return on Assets
RHHVF
ABBV
MRK
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
LLY
Eli Lilly and CoQxrv$743.1 Bil
JNJ
Johnson & JohnsonSqwd$390.5 Bil
MRK
Merck & Co IncWxzf$321.5 Bil
ABBV
AbbVie IncSxmkv$316.0 Bil
RHHBY
Roche Holding AG ADRYnjm$211.8 Bil
NVS
Novartis AG ADRShx$208.3 Bil
AZN
AstraZeneca PLC ADRHvd$197.3 Bil
AMGN
Amgen IncHghb$150.2 Bil
PFE
Pfizer IncVvz$150.1 Bil
SNY
Sanofi SA ADRYnv$117.8 Bil

Sponsor Center